Cargando…
Therapeutic Potential of Hematopoietic Prostaglandin D(2) Synthase in Allergic Inflammation
Worldwide, there is a rise in the prevalence of allergic diseases, and novel efficient therapeutic approaches are still needed to alleviate disease burden. Prostaglandin D(2) (PGD(2)) has emerged as a central inflammatory lipid mediator associated with increased migration, activation and survival of...
Autores principales: | Rittchen, Sonja, Heinemann, Akos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628301/ https://www.ncbi.nlm.nih.gov/pubmed/31226822 http://dx.doi.org/10.3390/cells8060619 |
Ejemplares similares
-
Monocytes and Macrophages Serve as Potent Prostaglandin D(2) Sources during Acute, Non-Allergic Pulmonary Inflammation
por: Rittchen, Sonja, et al.
Publicado: (2021) -
Prostaglandin terminal synthases as novel therapeutic targets
por: HARA, Shuntaro
Publicado: (2017) -
Improvement in the quality of hematopoietic prostaglandin D synthase crystals in a microgravity environment
por: Tanaka, Hiroaki, et al.
Publicado: (2011) -
Roles of lipocalin-type and hematopoietic prostaglandin D synthases in mouse retinal angiogenesis
por: Horikami, Daiki, et al.
Publicado: (2023) -
Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets
por: Peinhaupt, Miriam, et al.
Publicado: (2017)